{"id":"https://openalex.org/W2556513562","doi":"https://doi.org/10.1182/blood.v120.21.963.963","title":"Prospective Phase II Multicenter Study of Conditioning with Treosulfan, Fludarabine and Low-Dose (2 Gy) Total Body Irradiation Followed by Hematopoietic Cell Transplantation From Related or Unrelated Donors for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome","display_name":"Prospective Phase II Multicenter Study of Conditioning with Treosulfan, Fludarabine and Low-Dose (2 Gy) Total Body Irradiation Followed by Hematopoietic Cell Transplantation From Related or Unrelated Donors for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2556513562","doi":"https://doi.org/10.1182/blood.v120.21.963.963","mag":"2556513562"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.963.963","doi":"https://doi.org/10.1182/blood.v120.21.963.963","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.963.963","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069648775","display_name":"Boglarka Gyurkocza","orcid":"https://orcid.org/0000-0002-2933-2119","observed_orcids":["https://orcid.org/0000-0002-2933-2119"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Boglarka Gyurkocza","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041615072","display_name":"Jonathan Aaron Gutman","orcid":"https://orcid.org/0000-0002-1470-0716","observed_orcids":["https://orcid.org/0000-0002-1470-0716"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Gutman","raw_affiliation_strings":["University of Colorado, Denver, CO, Denver, CO, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Denver, CO, Denver, CO, USA,","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034117075","display_name":"Eneida R. Nemecek","orcid":"https://orcid.org/0000-0003-1522-8924","observed_orcids":["https://orcid.org/0000-0003-1522-8924"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eneida R. Nemecek","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR, USA,","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016751259","display_name":"Eileen J. Sickle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Eileen Sickle","raw_affiliation_strings":["University of Washington, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA,","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066212518","display_name":"Merav Bar","orcid":"https://orcid.org/0000-0001-5334-5158","observed_orcids":["https://orcid.org/0000-0001-5334-5158"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Merav Bar","raw_affiliation_strings":["University of Washington, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA,","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048585584","display_name":"Joachim Baumgart","orcid":"https://orcid.org/0000-0003-4502-2847","observed_orcids":["https://orcid.org/0000-0003-4502-2847"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Joachim Baumgart","raw_affiliation_strings":["medac GmbH, Hamburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"medac GmbH, Hamburg, Germany,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025632410","display_name":"Colleen S. Delaney","orcid":"https://orcid.org/0000-0002-1044-2801","observed_orcids":["https://orcid.org/0000-0002-1044-2801"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Delaney","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070467855","display_name":"Barry E. Storer","orcid":"https://orcid.org/0000-0003-1565-435X","observed_orcids":["https://orcid.org/0000-0003-1565-435X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Barry Storer","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056405520","display_name":"Frederick R. Appelbaum","orcid":"https://orcid.org/0000-0002-1839-5069","observed_orcids":["https://orcid.org/0000-0002-1839-5069"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frederick R. Appelbaum","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010962133","display_name":"H. Joachim Deeg","orcid":"https://orcid.org/0000-0002-4426-9023","observed_orcids":["https://orcid.org/0000-0002-4426-9023","https://orcid.org/0000-0001-5801-5457"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Joachim Deeg","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5016751259","https://openalex.org/A5048585584","https://openalex.org/A5066212518","https://openalex.org/A5069648775","https://openalex.org/A5070467855"],"corresponding_institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.203,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.62414657,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"120","issue":"21","first_page":"963","last_page":"963"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.049800001084804535,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9819999933242798},{"id":"https://openalex.org/keywords/high-risk-cytogenetics","display_name":"high-risk cytogenetics","score":0.8700000047683716},{"id":"https://openalex.org/keywords/treosulfan","display_name":"treosulfan","score":0.9829999804496765},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/low-dose-total-body-irradiation","display_name":"low-dose total body irradiation","score":0.9769999980926514},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.777999997138977},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.4390000104904175},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8140000104904175},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.7260000109672546},{"id":"https://openalex.org/keywords/donor-mismatch","display_name":"donor mismatch","score":0.3269999921321869},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.6660000085830688},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.9879999756813049},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.4740000069141388},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8641519546508789},{"id":"https://openalex.org/C2779178397","wikidata":"https://www.wikidata.org/wiki/Q7838652","display_name":"Treosulfan","level":5,"score":0.8357053399085999},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7056440114974976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6165176630020142},{"id":"https://openalex.org/C2778880498","wikidata":"https://www.wikidata.org/wiki/Q1986672","display_name":"Total body irradiation","level":4,"score":0.6142780780792236},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5629667043685913},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4851723313331604},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.4680590033531189},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.43482547998428345},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.4298960566520691},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.42636942863464355},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37131360173225403},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3679569363594055},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3530571460723877},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23608702421188354},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.11766830086708069}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.963.963","doi":"https://doi.org/10.1182/blood.v120.21.963.963","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.963.963","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2778104597","https://openalex.org/W2046152217","https://openalex.org/W2044357856","https://openalex.org/W4417004672","https://openalex.org/W7006529703","https://openalex.org/W2558118065","https://openalex.org/W2980336854","https://openalex.org/W1984432386","https://openalex.org/W2971903468","https://openalex.org/W2802896371"],"abstract_inverted_index":{"Abstract":[0,1],"963":[2],"Background:":[3],"We":[4],"showed":[5],"previously":[6],"that":[7,574],"a":[8,25,65,275,399,586],"transplant":[9],"conditioning":[10,490],"regimen":[11,491],"of":[12,28,69,77,128,212,251,278,303,321,344,350,447,474,504,616],"treosulfan":[13,107],"combined":[14],"with":[15,19,32,41,59,94,116,179,346,352,361,367,388,408,431,433,482,497,514,525,539,543,550,557,577],"fludarabine":[16,109,194,483],"was":[17,81,159,175,357,487,534],"associated":[18],"low":[20,42,526,536],"non-relapse":[21],"mortality":[22],"(NRM)":[23],"and":[24,87,112,136,202,237,260,263,293,297,307,314,327,337,348,363,396,410,416,422,427,456,484,509,547,620],"high":[26,544,579,592],"probability":[27],"survival":[29,68,90,292],"in":[30,57,64,71,92,144,157,177,234,243,285,342,365,406,420,440,467,480,495,512,523,537,575],"patients":[31,58,93,115,178,236,272,345,351,360,366,387,407,466,496,513,524,538,556,576],"acute":[33,326],"myeloid":[34],"leukemia":[35],"(AML)":[36],"or":[37,43,97,119,130,141,149,215,224,305,390,419,439,506,527],"myelodysplastic":[38],"syndrome":[39],"(MDS)":[40],"intermediate":[44,528],"risk":[45,156,375,413,424,529,545,580,593],"cytogenetics":[46,516,584],"(Nemecek":[47],"et":[48],"al,":[49],"BBMT":[50],"2011).":[51],"Relapse":[52,340,508],"rates":[53,403,452,511],"were":[54,122,125,229,295,312,334,404],"high,":[55],"however,":[56],"high-risk":[60,95,138,515],"cytogenetics,":[61,546],"which":[62],"resulted":[63],"2-year":[66,290,401],"relapse-free":[67],"39%":[70,343],"this":[72],"group.":[73],"Objective:":[74],"The":[75,300,319,531,571],"objective":[76],"the":[78,84,106,162,168,240,288,382,445,472,502],"present":[79],"study":[80],"to":[82,105,191,200,267,568],"reduce":[83],"relapse":[85,304,380,442,451,532],"incidence":[86],"improve":[88],"overall":[89],"(OS)":[91],"AML":[96,117,143,151,158,347,362,389,414,432,498,558,578],"MDS":[98,120,353,368,391,425],"by":[99,210,583,596],"adding":[100],"low-dose":[101,485],"TBI":[102,205,486],"(2":[103],"Gy)":[104],"plus":[108],"regimen.":[110],"Patients":[111,124,181,430],"methods:":[113],"Ninety-six":[114],"(n=60)":[118],"(n=36)":[121],"enrolled.":[123],"60":[126],"years":[127,311,333,464],"age":[129],"younger":[131],"(median":[132],"age:":[133],"50":[134],"years)":[135],"had":[137,449,585],"MDS,":[139,540],"unfavorable":[140,411],"intermediate-risk":[142],"first":[145,153],"complete":[146],"remission":[147,468],"(CR)":[148],"any":[150],"beyond":[152],"CR.":[154],"Cytogenetic":[155],"stratified":[160],"using":[161],"Southwest":[163],"Oncology":[164],"Group":[165],"criteria,":[166],"while":[167],"World":[169],"Health":[170],"Organization-based":[171],"Prognostic":[172],"Scoring":[173],"System":[174],"used":[176],"MDS.":[180,507],"received":[182],"intravenous":[183],"(IV)":[184],"treosulfan,":[185,479,617],"14":[186],"g/m2/day":[187],"on":[188,197,206,255,589],"days":[189,198,256],"-6":[190,199],"-4,":[192],"IV":[193],"30":[195],"mg/m2/day":[196],"-2,":[201],"2":[203,310,332,463],"Gy":[204],"day":[207],"0,":[208],"followed":[209],"infusion":[211],"marrow":[213],"(n=11)":[214],"peripheral":[216],"blood":[217],"stem":[218],"cells":[219],"(n=85)":[220],"from":[221,521],"related":[222],"(n=27)":[223],"unrelated":[225],"(n=69)":[226],"donors.":[227],"Donors":[228],"single":[230],"HLA":[231],"allele-level":[232],"mismatched":[233],"9":[235],"HLA-matched":[238],"at":[239,309,331,444,462,471,501,563],"allele":[241],"level":[242],"87":[244],"patients.":[245],"Graft-versus-host":[246],"disease":[247,436,562],"(GVHD)":[248],"prophylaxis":[249],"consisted":[250],"methotrexate":[252,619],"(10":[253],"mg/m2":[254],"+1,":[257],"+3,":[258],"+6":[259],"+11":[261],"post-HCT)":[262],"tacrolimus":[264,621],"(days":[265],"\u20131":[266],"+180).":[268],"Results:":[269],"All":[270],"evaluable":[271],"engrafted.":[273],"With":[274],"median":[276],"follow-up":[277],"12.8":[279],"(range,":[280],"0.2":[281],"\u2013":[282],"34.7)":[283],"months":[284],"surviving":[286],"patients,":[287],"estimated":[289],"progression-free":[291],"OS":[294,356,402,458,510],"59%":[296],"68%,":[298],"respectively.":[299,339],"cumulative":[301],"incidences":[302,320],"progression":[306],"NRM":[308],"30%":[313],"11%,":[315],"respectively":[316],"(Figure":[317,354,369],"1).":[318],"grade":[322],"II":[323],"(grades":[324],"III-IV)":[325],"extensive":[328],"chronic":[329],"GVHD":[330],"48%":[335],"(11%)":[336],"40%,":[338],"occurred":[341],"18%":[349],"2A).":[355],"61%":[358],"among":[359],"79%":[364],"2B).":[370],"In":[371,477],"univariate":[372],"analyses,":[373],"cytogenetic":[374,412],"status":[376],"did":[377,517],"not":[378,518],"impact":[379,588],"for":[381,386,492],"entire":[383],"cohort":[384],"nor":[385],"analyzed":[392],"separately":[393],"(Figures":[394],"3A":[395],"3B).":[397],"As":[398],"result,":[400],"similar":[405],"favorable/intermediate":[409],"(64%":[415],"57%,":[417],"respectively)":[418],"good/intermediate":[421],"poor":[423],"(88%":[426],"71%,":[428],"respectively).":[429],"minimal":[434],"residual":[435,561],"(MRD;":[437],"n=10)":[438],"refractory":[441],"(n=4)":[443],"time":[446,473,503],"HCT,":[448],"higher":[450],"(87%":[453],"vs.":[454,460],"25%)":[455],"lower":[457],"(25%":[459],"81%)":[461],"than":[465,591],"without":[469],"MRD":[470],"HCT.":[475],"Conclusions:":[476],"summary,":[478],"combination":[481],"an":[488],"effective":[489],"allogeneic":[493],"HCT":[494,564],"(in":[499],"CR":[500],"HCT)":[505],"differ":[519],"significantly":[520],"those":[522,542],"karyotypes.":[530],"rate":[533],"particularly":[535],"including":[541],"further":[548],"trials":[549],"treosulfan-based":[551],"regimens":[552,566],"are":[553],"warranted.":[554],"For":[555],"who":[559],"have":[560],"novel":[565],"need":[567],"be":[569,623],"developed.":[570],"data":[572],"suggest":[573],"as":[581,594,600],"defined":[582,595],"different":[587],"outcome":[590],"other":[597],"parameters,":[598],"such":[599],"tumor":[601],"burden.":[602],"Disclosures:":[603],"Gyurkocza:":[604],"medac":[605],"GmbH,":[606,626,632,637],"Hamburg,":[607,627,633,638],"Germany:":[608,628,634,639],"Research":[609,629,640],"Funding.":[610,630,641],"Off":[611],"Label":[612],"Use:":[613],"Off-label":[614],"usage":[615],"fludarabine,":[618],"will":[622],"discussed.":[624],"Sickle:medac":[625],"Baumgart:medac":[631],"Employment.":[635],"Deeg:medac":[636]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-11-30T00:00:00"}